BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Du L, Zhu S, Lu Z, Xu T, Bai T, Xu D, Wei X, Li J, Xu K, Ye J, Hou X, Song Y. Ascitic cholesterol is superior to serum-ascites albumin gradient in the detection of non-portal hypertensive ascites and the diagnosis of mixed ascites. Aliment Pharmacol Ther 2019;49:91-8. [PMID: 30443960 DOI: 10.1111/apt.15042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Du L, Zhu S, Hou X, Song Y. Editorial: ascitic cholesterol - is it superior to serum-ascites albumin gradient? Authors’ reply. Aliment Pharmacol Ther 2019;49:815-6. [DOI: 10.1111/apt.15105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Guo YY, Peng XL, Zhan N, Tian S, Li J, Dong WG. Development and validation a simple model for identify malignant ascites. Int J Med Sci 2021;18:1966-74. [PMID: 33850466 DOI: 10.7150/ijms.53743] [Reference Citation Analysis]
3 Liu F, Rong X, Guo H, Xu D, Liu C, Meng L, Yang X, Guo T, Kan X, Song Y. Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study. BMC Gastroenterol 2020;20:30. [PMID: 32019495 DOI: 10.1186/s12876-020-1180-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
4 Zhu S, Du L, Xu D, Lu Z, Xu T, Li J, Xu K, Ye J, Song Y. Ascitic fluid total protein, a useful marker in non-portal hypertensive ascites. J Gastroenterol Hepatol 2020;35:271-7. [PMID: 31247673 DOI: 10.1111/jgh.14768] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Patel SS, Siddiqui MS. Editorial: ascitic cholesterol-is it superior to serum-ascites albumin gradient? Aliment Pharmacol Ther 2019;49:814-5. [DOI: 10.1111/apt.15078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Du L, Wang D, Wei X, Liu C, Xiao Z, Qian W, Song Y, Hou X. MS275 as Class I HDAC inhibitor displayed therapeutic potential on malignant ascites by iTRAQ-based quantitative proteomic analysis. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02101-7] [Reference Citation Analysis]
7 Gan X, Yang J, Wang L, Tan B, Wang L. Application of PETCT imaging information combined with tumor markers in etiological screening of infectious and non-infectious ascites. J Infect Public Health 2020;13:1997-2000. [PMID: 31447404 DOI: 10.1016/j.jiph.2019.08.002] [Reference Citation Analysis]